本妥昔单抗
Anti-CD30 (brentuximab vedotin biosimilar) mAb
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
1 mg 5 mg 10 mg
Product Availability
3-5days
Price
$1500.00
Member price
Product Availability
3-5days
Price
$5100.00
Member price
Product Availability
3-5days
Price
$9100.00
Member price
Quantity
- +
Product Overview
Product Name Anti-CD30 (brentuximab vedotin biosimilar) mAb
CAS914088-09-8
Storage conditionSealed and stored at ≤-20℃, away from light. Avoid freeze-thaw cycles
Security information
Product details

Brentuximab vedotin (SGN-35; Adcetris,cAC10-vcMMAE) is an anti-CD30 antibody conjugated via a protease-cleavable linker to the potent anti-microtubule agent monomethyl auristatin E (MMAE). Brentuximab vedotin can be used for the research of relapsed and refractory Hodgkin lymphoma.

Related literature
Related
Sorry, no related items
History
Revaprazan hydrochloride; Revaprazan HCl
XAV-939
Anti-CD30 (brentuximab vedotin biosimilar) mAb
(E)-4-Hydroxy-N'-(naphthalen-2-ylmethylene)benzohydrazide (SLU-PP-332)
PD 169316
BAN ORL 24 free base
Tanshinone I | Tanshinone A
Gefitinib | ZD1839
Recombinant Human Interleukin 33 (rHulL-33)
δ-Sleep Inducing Peptide acetate (Delta-Sleep Inducing Peptide acetate)